Sands Capital Ventures, LLC Karuna Therapeutics, Inc. Transaction History

Sands Capital Ventures, LLC

  • $199 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 09, 2022
SELL
$123.79 - $277.42 $14.1 Million - $31.6 Million
-114,000 Reduced 65.94%
58,895 $13.2 Million
Q2 2022

Aug 12, 2022
SELL
$93.97 - $143.33 $8.93 Million - $13.6 Million
-95,000 Reduced 35.46%
172,895 $21.9 Million
Q3 2021

Nov 04, 2021
BUY
$101.2 - $125.87 $27.1 Million - $33.7 Million
267,895 New
267,895 $32.8 Million

Others Institutions Holding KRTX

# of Institutions
10
Shares Held
332K
Call Options Held
0
Put Options Held
0
View Full List

About Karuna Therapeutics, Inc.

KRTX Quotes by TradingView
  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Sands Capital Ventures, LLC Portfolio

Follow Sands Capital Ventures, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sands Capital Ventures, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sands Capital Ventures, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email